POLISCOPE
Back to feed

The civic record

Read. Follow. Verify.
High Impact

Congressional Hearing on Organ Transplant System Reform

Original title: THE URGENT NEED TO REFORM THE ORGAN TRANSPLANTATION SYSTEM TO SECURE MORE ORGANS FOR WAITING, AILING, AND DYING PATIENTS

Record date · January 1, 2021

Track this bill to get notified when it advances a stage. One tap to stop, anytime.

What This Bill Does

The House Subcommittee on Economic and Consumer Policy held a hearing on May 4, 2021, to examine the effectiveness of the U.S. organ transplantation system. The session featured testimony from patients, medical professionals, and industry representatives regarding the need for systemic improvements to increase organ availability.

Why it matters

This hearing initiates a formal legislative review of the national organ procurement and transplantation network, which directly impacts the wait times and survival rates for thousands of patients currently on transplant waiting lists.

Who It Affects

Groups the bill's text affects, as described in the record. Being affected is not a position for or against it.

Directly affected

Patients on transplant waiting lists

These individuals are directly impacted by the efficiency and policies of the organ procurement system.

Directly affected

Organ Procurement Organizations

These organizations are responsible for the recovery of organs and are the subject of the proposed systemic reforms.

Key Facts

  • The hearing took place on May 4, 2021, via Zoom.
  • The hearing focused on the 'Urgent Need to Reform the Organ Transplantation System'.
  • Witnesses included patients waiting for transplants, a living donor, medical directors, and representatives from organ procurement organizations.
  • The subcommittee received testimony from two panels of experts and stakeholders.
Show all 5 facts
  • Statements from the National Council on Disability and the American Society of Nephrology were entered into the record by unanimous consent.

Frequently Asked Questions

What was the purpose of this hearing?
The hearing was held to investigate the current organ transplantation system in the U.S. and discuss potential reforms to increase the number of available organs for patients.
Who testified at the hearing?
The hearing featured two panels: the first included patients and a , and the second included medical directors and leaders of organ procurement organizations.

What else do you want to know?

News Coverage

No news coverage found yet. Articles are indexed twice daily.

Full breakdown

Who this bill affects and the strongest case for and against it, written only from the bill’s own text.

Discoveries

1 pattern noticed across the record

Patterns POLISCOPE noticed across the record. These are observations to investigate, not conclusions.

policy shift80% confidence

Focus on OPO Accountability

The hearing signals a shift toward increased federal scrutiny of Organ Procurement Organizations to improve transplant outcomes.

Connected Entities

Raja Krishnamoorthi, Dr. Dara Kass, Tonya Ingram and 2 more
PersonRaja Krishnamoorthi“Chairman of the Subcommittee on Economic and Consumer Policy”Map →
PersonDr. Dara Kass“Witness, living donor, and mother of a transplant recipient”Map →
PersonTonya Ingram“Patient witness waiting for an organ transplant”Map →
OrganizationSubcommittee on Economic and Consumer Policy“Congressional body conducting the hearing”Map →
OrganizationAssociation for Organ Procurement Organizations“Industry group represented by witnesses Steve Miller and Joe Ferreira”Map →

Sources

Open source document

www.govinfo.gov

Analysis Score

0–100
  • Significance75
    How much this matters to a regular citizen
  • Controversy40
    Intensity of disagreement among stakeholders
  • Entertainment20
    Compellingness for a non-policy-wonk reader
  • Buzz30
    Current news / social attention level

Publisher tools

Share or embed this record

POLISCOPE publisher tools

Share or embed this record